What Researchers Did
Researchers will conduct a prospective observational study to evaluate inflammatory and vasoactive biomarkers as prognostic markers in 114 patients with necrotising soft tissue infections (NSTIs) and to investigate the effects of hyperbaric oxygen treatment (HBOT) on these biomarkers.
What They Found
This study is a protocol describing a prospective observational cohort study, so no results or findings are available yet. Researchers plan to enroll 114 patients with necrotising soft tissue infections and measure biomarkers like pentraxin-3, interleukin-6, and nitrite daily for up to 7 days. The primary analysis will focus on these biomarkers as early indicators of disease severity.
What This Means for Canadian Patients
If successful, this research could lead to the identification of biomarkers that help Canadian clinicians quickly identify high-risk patients with necrotising soft tissue infections upon admission. This could potentially improve patient management and outcomes by enabling earlier, more targeted interventions.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a study protocol, the actual findings and their generalizability are yet to be determined.